CHAMPIX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug CHAMPIX contains one active pharmaceutical ingredient (API):

1 Varenicline UNII 82269ASB48 - VARENICLINE TARTRATE

Varenicline binds with high affinity and selectivity at the α4β2 neuronal nicotinic acetylcholine receptors, where it acts as a partial agonist – a compound that has both agonist activity, with lower intrinsic efficacy than nicotine, and antagonist activities in the presence of nicotine. Read about Varenicline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CHAMPIX Film-coated tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07BA03	Varenicline	N Nervous system → N07 Other nervous system drugs → N07B Drugs used in addictive disorders → N07BA Drugs used in nicotine dependence
Discover more medicines within N07BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5469W, 9128K, 9129L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522720070088717, 522720070088817, 522720070088917, 522720070089017, 522720070089117, 522720070089217
Country: CA	Health Products and Food Branch	Identifier(s): 02291177, 02291185, 02298309
Country: EE	Ravimiamet	Identifier(s): 1260346, 1260357, 1260368, 1260379, 1260380, 1295771, 1403042, 1501625, 1774380
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06360001, 06360004IP, 06360011IP, 06360012IP, 106360016, 106360022, 106360023
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 058014, 066260, 130596, 161488, 551683
Country: FR	Base de données publique des médicaments	Identifier(s): 60442838, 65586162, 66287152
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 109714, 109717, 109808, 109810, 109813, 112763, 178966, 178968, 178969, 178971, 324738
Country: HK	Department of Health Drug Office	Identifier(s): 55437, 55462, 55479
Country: IE	Health Products Regulatory Authority	Identifier(s): 17118, 17120, 17125, 17136, 17143, 34565, 34571, 34574, 34586, 34605, 34608
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6091, 6144, 6236, 7326
Country: JP	医薬品医療機器総合機構	Identifier(s): 7990003F1028, 7990003F2024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028217, 1028218, 1028219, 1028220, 1028221, 1028222, 1028223, 1028224, 1028225, 1028226, 1028227, 1061950, 1061951, 1074095, 1074096, 1074097, 1074098, 1074099, 1074100, 1074101, 1074102, 1074103, 1074105, 1074106, 1085096, 1085097
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 339M2006
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 82597, 82600, 82619
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12360, 12361, 13087
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100164017, 100164023, 100164030
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64807002, W64808001, W64808002, W64808003
Country: SG	Health Sciences Authority	Identifier(s): 13322P, 13323P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308097484, 8681308097491, 8681308097514, 8681308097521, 8681308098863, 8699532097507
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/34/0574